Terms: = Breast cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Treatment
15 results:
1. Comprehensive genomic profiling to identify actionable alterations for breast cancer brain metastases in the Chinese population.
Lu Q; Wang N; Jiang K; Zhou H; Zhang P; Zhang J; Wang S; Sun P; Xu F
ESMO Open; 2024 Mar; 9(3):102389. PubMed ID: 38460250
[TBL] [Abstract] [Full Text] [Related]
2. Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of cancer stem cells.
Ferrer-Diaz AI; Sinha G; Petryna A; Gonzalez-Bermejo R; Kenfack Y; Adetayo O; Patel SA; Hooda-Nehra A; Rameshwar P
Cell Commun Signal; 2024 Feb; 22(1):119. PubMed ID: 38347590
[TBL] [Abstract] [Full Text] [Related]
3. [Application value of DNA damage repair variants in adjuvant therapy of triple negative breast cancer].
Wang X; Yue J; Kang YK; Gao SL; Yuan P
Zhonghua Zhong Liu Za Zhi; 2023 Sep; 45(9):787-795. PubMed ID: 37805443
[No Abstract] [Full Text] [Related]
4. MRI-based breast cancer radiogenomics using RNA profiling: association with subtypes in a single-center prospective study.
Park AY; Han MR; Seo BK; Ju HY; Son GS; Lee HY; Chang YW; Choi J; Cho KR; Song SE; Woo OH; Park HS
Breast Cancer Res; 2023 Jun; 25(1):79. PubMed ID: 37391754
[TBL] [Abstract] [Full Text] [Related]
5. breast cancer Cell Detection and Characterization from breast Milk-Derived Cells.
Bhat-Nakshatri P; Kumar B; Simpson E; Ludwig KK; Cox ML; Gao H; Liu Y; Nakshatri H
Cancer Res; 2020 Nov; 80(21):4828-4839. PubMed ID: 32934021
[TBL] [Abstract] [Full Text] [Related]
6. Actionable co-alterations in breast tumors with pathogenic mutations in the homologous recombination DNA damage repair pathway.
Heeke AL; Xiu J; Elliott A; Korn WM; Lynce F; Pohlmann PR; Isaacs C; Swain SM; Vidal G; Schwartzberg LS; Tan AR
Breast Cancer Res Treat; 2020 Nov; 184(2):265-275. PubMed ID: 32776290
[TBL] [Abstract] [Full Text] [Related]
7. Integrated molecular profiling of young and elderly patients with triple-negative breast cancer indicates different biological bases and clinical management strategies.
Ma D; Jiang YZ; Xiao Y; Xie MD; Zhao S; Jin X; Xu XE; Shao ZM
Cancer; 2020 Jul; 126(14):3209-3218. PubMed ID: 32383785
[TBL] [Abstract] [Full Text] [Related]
8. Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin.
Yao H; Veine DM; Livant DL
Breast Cancer Res Treat; 2016 Jun; 157(3):489-501. PubMed ID: 27255534
[TBL] [Abstract] [Full Text] [Related]
9. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity.
Liu SY; Joseph NM; Ravindranathan A; Stohr BA; Greenland NY; Vohra P; Hosfield E; Yeh I; Talevich E; Onodera C; Van Ziffle JA; Grenert JP; Bastian BC; Chen YY; Krings G
Mod Pathol; 2016 Sep; 29(9):1012-27. PubMed ID: 27255162
[TBL] [Abstract] [Full Text] [Related]
10. Genomic profiling of advanced-stage, metaplastic breast carcinoma by next-generation sequencing reveals frequent, targetable genomic abnormalities and potential new treatment options.
Ross JS; Badve S; Wang K; Sheehan CE; Boguniewicz AB; Otto GA; Yelensky R; Lipson D; Ali S; Morosini D; Chliemlecki J; Elvin JA; Miller VA; Stephens PJ
Arch Pathol Lab Med; 2015 May; 139(5):642-9. PubMed ID: 25927147
[TBL] [Abstract] [Full Text] [Related]
11. Quality of life and cosmesis after breast cancer: whole breast radiotherapy vs partial breast high-dose-rate brachytherapy.
Perrucci E; Lancellotta V; Bini V; Falcinelli L; Farneti A; Margaritelli M; Capezzali G; Palumbo I; Aristei C
Tumori; 2015; 101(2):161-7. PubMed ID: 25768319
[TBL] [Abstract] [Full Text] [Related]
12. Phosphorylated and sumoylation-deficient progesterone receptors drive proliferative gene signatures during breast cancer progression.
Knutson TP; Daniel AR; Fan D; Silverstein KA; Covington KR; Fuqua SA; Lange CA
Breast Cancer Res; 2012 Jun; 14(3):R95. PubMed ID: 22697792
[TBL] [Abstract] [Full Text] [Related]
13. Targeted therapies for non-small cell lung cancer.
Dempke WC; Suto T; Reck M
Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
[TBL] [Abstract] [Full Text] [Related]
14. Glyburide for the treatment of gestational diabetes mellitus.
Kimber-Trojnar Z; Marciniak B; Leszczyńska-Gorzelak B; Trojnar M; Oleszczuk J
Pharmacol Rep; 2008; 60(3):308-18. PubMed ID: 18622055
[TBL] [Abstract] [Full Text] [Related]
15. cancer of the breast: Its outcome as measured by the rate of dying and causes of death.
Mueller CB; Jeffries W
Ann Surg; 1975 Sep; 182(3):334-41. PubMed ID: 1174299
[TBL] [Abstract] [Full Text] [Related]
